Share:
Peer-Reviewed Publication
Contemp Clin Trials2026;160108149.January 1, 2026Journal Article

Evaluating effectiveness and engagement strategies for asynchronous, messaging, trauma-focused therapy for posttraumatic stress disorder: Study design and methodology for a hybrid effectiveness-implementation randomized controlled trial.

Katherine A Dondanville1, Amber Calloway2, Elizabeth C Stade3, Thomas D Hull4, Booil Jo5, Szu-Chi Huang5, Brittany N Hall-Clark6, Stefanie T LoSavio6, Bailee Schuhmann6, Sohayla Elhusseini7, Nicole Fridling-Cook4, Cyrus Pattee6, Aarthi Padmanabhan4, Shannon Wiltsey Stirman7
1Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at San Antonio, United States of America. Electronic address: Dondanville@uthscsa.edu.
2Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, United States of America.
3Institute of Human-Centered Artificial Intelligence, Stanford University, Palo Alto, CA, United States of America; Department of Psychology, Stanford University, Palo Alto, CA, United States of America.
4Talkspace, New York, NY, United States of America.
5Institute of Human-Centered Artificial Intelligence, Stanford University, Palo Alto, CA, United States of America.
6Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at San Antonio, United States of America.
7National Center for PTSD, VA Palo Alto Healthcare System, United States of America; Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, United States of America.

Abstract

Posttraumatic stress disorder (PTSD) can be a chronic and debilitating condition with significant individual and societal costs. Despite the availability of effective, trauma-focused treatments like Cognitive Processing Therapy (CPT), access and sustained engagement remain limited due to logistical, financial, and stigma-related barriers. The current study utilized a hybrid effectiveness-implement…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.